|1.||Welch, Rodney A: 3 articles (02/2011 - 07/2006)|
|2.||Xu, Dingguo: 2 articles (09/2013 - 09/2012)|
|3.||Zheng, Min: 2 articles (09/2013 - 09/2012)|
|4.||Szabady, Rose L: 2 articles (02/2011 - 02/2009)|
|5.||Nalini, Namasivayam: 2 articles (10/2006 - 04/2004)|
|6.||Manju, Vaiyapuri: 2 articles (10/2006 - 04/2004)|
|7.||Girish, K S: 2 articles (02/2006 - 01/2006)|
|8.||Kemparaju, K: 2 articles (02/2006 - 01/2006)|
|9.||Hicks, S J: 2 articles (11/2002 - 12/2001)|
|10.||Wiggins, R: 2 articles (11/2002 - 12/2001)|
11/01/2005 - "A novel bacterial mucinase, glycosulfatase, is associated with bacterial vaginosis."
11/01/2002 - "Application of a novel human cervical mucin-based assay demonstrates the absence of increased mucinase activity in bacterial vaginosis."
04/01/1994 - "Sialidase activity was associated with bacterial vaginosis-linked organisms (Gardnerella vaginalis, Mobiluncus spp, and Mycoplasma hominis) and Chlamydia trachomatis and yeast species; mucinase activity was associated only with bacterial vaginosis-linked microorganisms. "
04/01/1994 - "Mucinase and sialidase activities were more commonly identified, and they occurred in higher concentrations, if present, in women with bacterial vaginosis (mucinase: 44.3% with bacterial vaginosis vs 27.4% without, p = 0.007; sialidase: 45% with bacterial vaginosis vs 12% without p < 0.001). "
04/01/1994 - "Clindamycin, 2% cream, was effective treatment for bacterial vaginosis and temporarily reduced mucinase and sialidase activities. "
02/01/2011 - "Our results indicate that TagA is a mucinase and suggest that TagA may directly modify host cell surface molecules during V. cholerae infection."
02/01/2009 - "Our data suggest that the StcE mucinase can play an immunomodulatory role by directly altering neutrophil function during infection. "
07/01/2006 - "This evidence supports a model which includes two roles for StcE during infection, in which StcE acts first as a mucinase and then as an anti-inflammatory agent by localizing C1-INH to cell membranes."
07/01/1953 - "[Significance of spreading factor in the phenomenon of infection and immunity]."
07/01/1943 - "It is probable that the spread of the virus produced by the bacteria is only partly responsible for the development of the complex infection and that products of these organisms other than the spreading factor play a large part in the mortality of embryos receiving the combination of virus and bacterium."
|3.||Rheumatic Fever (Acute Articular Rheumatism)
05/01/1949 - "Relation of the hemolytic streptococcus to rheumatic fever; effect of streptococcic spreading factor in rheumatic patients and others."
05/26/1954 - "[Biological study of five cases of acute articular rheumatism treated with corticotrophin and cortisone; evaluation of the urinary corticoids and of the skin spreading factor]."
09/05/2013 - "Catalytic mechanism of hyaluronate lyase from Streptococcus pneumonia [corrected] : quantum mechanical/molecular mechanical and density functional theory studies."
09/05/2013 - "Finally, in combination of our previous molecular dynamics simulations, a complete catalytic cycle for the degradation of hyaluronan tetrasaccharide catalyzed by the hyaluronate lyase from Spectrococcus pneumonia is proposed. "
09/05/2013 - "Hyaluronate lyase from Spectrococcus pneumonia can degrade hyaluronic acid, which is one of the major components in the extracellular matrix. "
09/13/2012 - "Hyaluronate lyase from Spectrococcus pneumonia can degrade hyaluronic acid, which is one of the major components in the extracellular matrix. "
|5.||Virulence Factors (Pathogenicity Factors)
|7.||Gonadal Steroid Hormones (Sex Hormones)
|10.||Adrenocorticotropic Hormone (ACTH)